KRAS and pancreatic intraductal papillary-mucinous neoplasm: This SMAD4-dependent phenotype may be influenced by TGF-β superfamily ligands such as activin, as loss of activin receptor 1B (ACVR1B) accelerates IPMN-to-PDAC progression in the context of oncogenic Kras [40].